Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

3Total
Not Applicable (1)
P 1 (1)
P 2 (1)

Trial Status

Active Not Recruiting2
Recruiting1

Clinical Trials (3)

Showing 3 of 3 trials
NCT04657068Phase 1Recruiting

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

NCT02834013Phase 2Active Not RecruitingPrimary

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

NCT02757859Not ApplicableActive Not RecruitingPrimary

WASH Trial: Intraoperative Lavage as a Treatment for Pancreatic Cancer

Showing all 3 trials

Research Network

Activity Timeline